Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.0B | 6.6B | 6.0B |
Cost of revenue | -1.5B | 2.0B | 2.2B | 2.0B |
Gross profit | 7.5B | 3.9B | 4.4B | 4.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.2B | 1.1B | 1.1B | 1.1B |
Operating income | 4.7B | 1.2B | 1.7B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 50M | 53M | 60M | 60M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.4B | 1.8B | 1.5B |
Tax provision | -21M | 402M | 523M | 421M |
Net income | 1.6B | 981M | 1.3B | 1.1B |
Basic EPS | — | 11.6 | 15.5 | 12.8 |
Diluted EPS | — | 11.6 | 15.5 | 12.8 |
Basic average shares | — | 83.4M | 83.2M | 83.2M |
Diluted average shares | — | 83.5M | 83.5M | 83.4M |
EBITDA | 1.9B | 1.8B | 2.2B | 1.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -7M | -14M | -16M | -14M |
Preferred stock dividends | 0 | 0 | 0 | 0 |